OA11875A - 1-Amino triazolo Ä4,3-aÜquinazoline-5-ones et/ou- 5-thiones inhibitrices de phosphodiesterases IV. - Google Patents
1-Amino triazolo Ä4,3-aÜquinazoline-5-ones et/ou- 5-thiones inhibitrices de phosphodiesterases IV. Download PDFInfo
- Publication number
- OA11875A OA11875A OA1200100282A OA1200100282A OA11875A OA 11875 A OA11875 A OA 11875A OA 1200100282 A OA1200100282 A OA 1200100282A OA 1200100282 A OA1200100282 A OA 1200100282A OA 11875 A OA11875 A OA 11875A
- Authority
- OA
- OAPI
- Prior art keywords
- triazolo
- quinazolin
- bromo
- pyrrolidin
- azepan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905398A FR2792938B1 (fr) | 1999-04-28 | 1999-04-28 | NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV |
Publications (1)
Publication Number | Publication Date |
---|---|
OA11875A true OA11875A (en) | 2006-03-29 |
Family
ID=9544983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200100282A OA11875A (en) | 1999-04-28 | 2000-04-28 | 1-Amino triazolo Ä4,3-aÜquinazoline-5-ones et/ou- 5-thiones inhibitrices de phosphodiesterases IV. |
Country Status (34)
Country | Link |
---|---|
US (1) | US6828315B1 (sk) |
EP (1) | EP1177195B1 (sk) |
JP (1) | JP2002543199A (sk) |
KR (1) | KR20020008166A (sk) |
CN (1) | CN1352644A (sk) |
AP (1) | AP2001002309A0 (sk) |
AT (1) | ATE234840T1 (sk) |
AU (1) | AU4411500A (sk) |
BG (1) | BG106026A (sk) |
BR (1) | BR0010072A (sk) |
CA (1) | CA2388658A1 (sk) |
DE (1) | DE60001735T2 (sk) |
DK (1) | DK1177195T3 (sk) |
DZ (1) | DZ3154A1 (sk) |
EA (1) | EA004373B1 (sk) |
EE (1) | EE200100566A (sk) |
ES (1) | ES2194779T3 (sk) |
FR (1) | FR2792938B1 (sk) |
HK (1) | HK1044938B (sk) |
HR (1) | HRP20010794B1 (sk) |
HU (1) | HUP0202656A3 (sk) |
IL (1) | IL146178A0 (sk) |
IS (1) | IS6114A (sk) |
MA (1) | MA27343A1 (sk) |
MX (1) | MXPA01010888A (sk) |
NO (1) | NO20015235L (sk) |
OA (1) | OA11875A (sk) |
PL (1) | PL351951A1 (sk) |
PT (1) | PT1177195E (sk) |
SK (1) | SK15322001A3 (sk) |
TR (1) | TR200103099T2 (sk) |
WO (1) | WO2000066584A1 (sk) |
YU (1) | YU76401A (sk) |
ZA (1) | ZA200108847B (sk) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
PA8539501A1 (es) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Compuestos triazolo como inhibidores de mmp |
US20040146561A1 (en) * | 2001-05-23 | 2004-07-29 | Naoki Sakurai | Compositions for promoting healing of bone fracture |
EP1285922A1 (en) | 2001-08-13 | 2003-02-26 | Warner-Lambert Company | 1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
FR2832711B1 (fr) | 2001-11-26 | 2004-01-30 | Warner Lambert Co | Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation |
DE10229778A1 (de) * | 2002-07-03 | 2004-01-29 | Bayer Ag | Neue Verwendung von Imidazotriazinonen |
CA2504820C (en) | 2002-11-06 | 2011-08-23 | Grelan Pharmaceutical Co., Ltd. | Pyrazolonaphthyridine derivatives |
EP1581535B3 (en) * | 2003-01-09 | 2009-09-02 | Astellas Pharma Inc. | Pyrrolopyridazine derivatives |
CA2563377A1 (en) * | 2004-04-23 | 2005-11-03 | Celgene Corporation | Methods of using and compositions comprising pde4 modulators for the treatment and management of pulmonary hypertension |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
AU2007292848A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
JP2010505811A (ja) | 2006-10-04 | 2010-02-25 | ファイザー・プロダクツ・インク | カルシウム受容体アンタゴニストとしてのピリド[4,3−d]ピリミジン−4(3H)−オン誘導体 |
WO2009013286A1 (en) * | 2007-07-24 | 2009-01-29 | Novartis Ag | Organic compounds |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
CN103224498B (zh) * | 2013-05-07 | 2015-10-28 | 陈定奔 | 两种唑并喹唑啉酮稠杂环的新合成方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3865824A (en) * | 1972-03-07 | 1975-02-11 | Icn Pharmaceuticals | 2-Aryl-7-substituted pyrazolo {8 1,5{i a{b {9 1,3,5-triazines |
US3850932A (en) * | 1973-06-28 | 1974-11-26 | Sandoz Ag | 5-(2-carboxy and 2-carboalkoxy-phenylamino)-1,2,4-triazolo-quinazolines |
IL66835A (en) * | 1981-09-24 | 1988-05-31 | Roussel Uclaf | 1,4-disubstituted(1,2,4)triazolo(4,3-alpha)quinazolin-5(4h)-one derivatives and their salts,their preparation and pharmaceutical compositions containing them |
JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
DK0837860T3 (da) * | 1995-06-06 | 2002-05-27 | Pfizer | Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner |
ES2137113B1 (es) * | 1997-07-29 | 2000-09-16 | Almirall Prodesfarma Sa | Nuevos derivados de triazolo-piridazinas heterociclicos. |
-
1999
- 1999-04-28 FR FR9905398A patent/FR2792938B1/fr not_active Expired - Lifetime
-
2000
- 2000-04-28 EP EP00967407A patent/EP1177195B1/fr not_active Expired - Lifetime
- 2000-04-28 AU AU44115/00A patent/AU4411500A/en not_active Abandoned
- 2000-04-28 HU HU0202656A patent/HUP0202656A3/hu unknown
- 2000-04-28 CN CN00808153A patent/CN1352644A/zh active Pending
- 2000-04-28 SK SK1532-2001A patent/SK15322001A3/sk unknown
- 2000-04-28 TR TR2001/03099T patent/TR200103099T2/xx unknown
- 2000-04-28 ES ES00967407T patent/ES2194779T3/es not_active Expired - Lifetime
- 2000-04-28 MX MXPA01010888A patent/MXPA01010888A/es active IP Right Grant
- 2000-04-28 US US09/980,540 patent/US6828315B1/en not_active Expired - Fee Related
- 2000-04-28 AT AT00967407T patent/ATE234840T1/de not_active IP Right Cessation
- 2000-04-28 PL PL00351951A patent/PL351951A1/xx not_active Application Discontinuation
- 2000-04-28 OA OA1200100282A patent/OA11875A/fr unknown
- 2000-04-28 YU YU76401A patent/YU76401A/sh unknown
- 2000-04-28 DE DE60001735T patent/DE60001735T2/de not_active Expired - Fee Related
- 2000-04-28 DZ DZ003154A patent/DZ3154A1/xx active
- 2000-04-28 EA EA200100994A patent/EA004373B1/ru not_active IP Right Cessation
- 2000-04-28 KR KR1020017013825A patent/KR20020008166A/ko not_active Application Discontinuation
- 2000-04-28 EE EEP200100566A patent/EE200100566A/xx unknown
- 2000-04-28 JP JP2000615614A patent/JP2002543199A/ja active Pending
- 2000-04-28 IL IL14617800A patent/IL146178A0/xx unknown
- 2000-04-28 WO PCT/FR2000/001174 patent/WO2000066584A1/fr active Search and Examination
- 2000-04-28 PT PT00967407T patent/PT1177195E/pt unknown
- 2000-04-28 CA CA002388658A patent/CA2388658A1/en not_active Abandoned
- 2000-04-28 BR BR0010072-2A patent/BR0010072A/pt not_active IP Right Cessation
- 2000-04-28 DK DK00967407T patent/DK1177195T3/da active
- 2000-04-28 AP APAP/P/2001/002309A patent/AP2001002309A0/en unknown
-
2001
- 2001-10-18 BG BG106026A patent/BG106026A/bg unknown
- 2001-10-19 IS IS6114A patent/IS6114A/is unknown
- 2001-10-23 MA MA26381A patent/MA27343A1/fr unknown
- 2001-10-26 ZA ZA200108847A patent/ZA200108847B/xx unknown
- 2001-10-26 HR HR20010794A patent/HRP20010794B1/xx not_active IP Right Cessation
- 2001-10-26 NO NO20015235A patent/NO20015235L/no not_active Application Discontinuation
-
2002
- 2002-08-05 HK HK02105712.4A patent/HK1044938B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1177195B1 (fr) | 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES ET/OU -5-THIONES INHIBITRICES DE PHOSPHODIESTERASES IV | |
US6747035B2 (en) | 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors | |
EP1086105B1 (en) | Fused azepinone cyclin dependent kinase inhibitors | |
US5840895A (en) | Triazole intermediates for tricyclic benzazepine and benzothiazepine derivatives | |
JP2005529843A (ja) | トリアゾロ[4,3−a]ピリド[2,3−d]ピリミジン−5−オン、それらを含有する組成物、その製造方法及び使用 | |
EP1556382B1 (fr) | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique. | |
TW201300390A (zh) | 喹□啉化合物 | |
EP1590355A1 (fr) | Derives d azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
KR100845749B1 (ko) | 트리시클, 이의 제조 및 약학적 제제로서의 용도 | |
Nguyen et al. | Synthesis, in vitro α-glucosidase, and acetylcholinesterase inhibitory activities of novel indol-fused pyrano [2, 3-d] pyrimidine compounds | |
EP1092715B1 (fr) | Composés cyano-indoles inhibiteurs de recapture de sérotonine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
CZ20022222A3 (cs) | Nové substituované pyrazolo [4,3-e] diazepiny, farmaceutické kompozice obsahující tyto diazepiny, jejich použití jako léčiva a způsoby jejich přípravy | |
FR2704547A1 (fr) | Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. | |
JP2001512124A (ja) | 新規な2,3−ベンゾジアゼピン誘導体 | |
HUT63423A (en) | Process for producing tetracyclic diimidazo- and imidazopyrimido quinazoline derivatives and pharmaceutical compositions comprising same | |
US6962912B2 (en) | Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them | |
LU84775A1 (fr) | Nouveaux derives cycloaliphatiques condenses de pyrido(1,2-a)pyrimidines substituees |